AMIX - Company ID 0001617867
The table below shows Autonomix Medical, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | - | $0.00 | $0.00 |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $1.72M | $2.37M | $1.59M | - | $1.04M | $1.17M |
| SG&A |
Autonomix Medical, Inc. reported annual revenue of $0.00 for fiscal year 2026. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.62M |
| $5.17M |
| $1.83M |
| - |
| $1.70M |
| $1.66M |
| Operating income | -$3.34M | -$7.53M | -$3.42M | - | -$2.75M | -$2.84M |
| Income tax | $0.00 | $0.00 | $0.00 | - | $0.00 | $0.00 |
| Net income | -$3.26M | -$7.45M | -$3.34M | -$11.41M | -$2.71M | -$2.81M |
| EPS (diluted) | - | - | - | - | - | - |